Formula Grant X98SM090687
- The Substance Abuse and Mental Health Services Administration (SAMHSA), within the U.S. Department of Health and Human Services, has awarded a $666,721 Formula Grant to Disability Rights Florida Inc. (doing business as Advocacy Center For Persons With Disabilities Inc.) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). This 24-month grant, running from October 1, 2025 to September 30, 2027, supports the organization's efforts to protect and...
- The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the U.S. Department of Health and Human Services, has awarded a $174,645 Formula Grant to Disability Rights South Carolina Inc. under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). This 24-month grant, effective from October 1, 2025 to September 30, 2027, will enable Disability Rights South Carolina Inc. to pursue administrative, legal, and other remedies to...
- This federal Formula Grant award from the Substance Abuse and Mental Health Services Administration (SAMHSA) in the U.S. Department of Health and Human Services provides $158,333 to Disability Rights Mississippi, the state's designated protection and advocacy system, to deliver legal advocacy, rights protection, and other services under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). The funding supports Disability Rights Mississippi's efforts to...
- The federal Formula Grant award of $158,333.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) supports Disability Rights Idaho, Inc. in providing legal advocacy, training, information and referral services, investigations of abuse and neglect, support for self-advocacy, assistance with accessing government programs, monitoring of facilities, ensuring voting...
- The U.S. Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $158,333 Formula Grant under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138) to Disability Rights Rhode Island (DRRI). This 24-month grant, effective from October 1, 2025 to September 30, 2027, will enable DRRI to pursue administrative, legal, and other remedies to address complaints of abuse, neglect, and rights violations...
- The federal Formula Grant award of $158,333.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) of the U.S. Department of Health and Human Services supports the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program administered by Disability Rights Arkansas Inc. This 24-month grant, active from October 1, 2025 to September 30, 2027, enables Disability Rights Arkansas Inc. to pursue administrative, legal, and other remedies to address complaints of...
- The federal Formula Grant award of $158,333.00 from the Substance Abuse and Mental Health Services Administration (SAMHSA) within the U.S. Department of Health and Human Services provides funding for the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program. This program, with the CFDA number 93.138, is intended to protect and advocate for the rights of adults with Significant Mental Illness (SMI) and children with Significant Emotional Disturbances (SED), particularly...
- This federal Formula Grant award of $217,255.00, provided by the Substance Abuse and Mental Health Services Administration (SAMHSA) of the U.S. Department of Health and Human Services under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138), supports the designated Protection and Advocacy system in the state of Washington, Disability Rights Washington. This funding enables Disability Rights Washington to deliver systemic advocacy, individual legal...
- This is a $158,333 Formula Grant awarded by the Department of Health and Human Services' Substance Abuse and Mental Health Services Administration (SAMHSA) to Disability Rights Maine (DRM), also known as Maine Advocacy Services, under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). The purpose of the PAIMI program is to pursue administrative, legal, and other remedies to address complaints of abuse, neglect, and rights violations, and to protect and...
- The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $158,333 Formula Grant titled "Protection and Advocacy for Individuals with Mental Illness" (CFDA 93.138) to Disability Rights Montana. This 24-month grant, effective from October 1, 2025 to September 30, 2027, supports Disability Rights Montana's efforts to protect the rights and advocate for adults with Significant Mental Illness (SMI) and children with Significant Emotional Disturbances (SED). The grant...
The Substance Abuse and Mental Health Services Administration (SAMHSA) awarded a $158,333 Formula Grant to Disability Rights Oregon under the Protection and Advocacy for Individuals with Mental Illness (PAIMI) program (CFDA 93.138). The grant will provide funding from October 1, 2025 to September 30, 2027 to support Disability Rights Oregon's efforts to protect the rights of adults with Significant Mental Illness (SMI) and children with Significant Emotional Disturbances (SED). The organization will use the grant funds to pursue administrative, legal, and other remedies to address complaints of abuse, neglect, and rights violations for these vulnerable populations, helping to ensure their constitutional and statutory protections are upheld. Disability Rights Oregon has extensive experience delivering critical services to individuals with disabilities through various federal grant programs, including legal advocacy, benefits counseling, assistive technology support, and community integration initiatives.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $158.3k | 12/30/25 |